Cross-talk between IGF-I and TGF-β signaling pathways

Cytokine and Growth Factor Reviews

Volumn 17, Issue 1-2, 2006, Pages 59-74

  Danielpour, David ^a,b   Song, Kyung ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ireland Cancer Center   (United States)

Author keywords

Akt; IGF I; mTOR; Prostate; Smad; TGF

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANDROGEN; AP 23573; BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; EVEROLIMUS; INITIATION FACTOR 4E BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; LIPOPROTEIN RECEPTOR; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN; RHO KINASE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FOXO; TRANSFORMING GROWTH FACTOR BETA; TUBERIN; TUMOR PROMOTER; TUMOR SUPPRESSOR PROTEIN;

ANTIFUNGAL ACTIVITY; APOPTOSIS; CARCINOGENESIS; CARCINOMA; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; ENZYME ACTIVATION; EPITHELIUM CELL; GENE INDUCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; MALIGNANT TRANSFORMATION; MESENCHYME CELL; METASTASIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 30944434575     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.09.007     Document Type: Article

References (212)

1. A.B. Roberts, and M.B. Sporn The transforming growth factor beta 1990 Springer-Verlag New York
2. J. Massague, and Y.G. Chen Controlling TGF-beta signaling Genes Dev 14 6 2000 627 644
3. J.L. Wrana, and L. Attisano The Smad pathway Cytokine Growth Factor Rev 11 1-2 2000 5 13
4. A.B. Roberts, and L.M. Wakefield The two faces of transforming growth factor beta in carcinogenesis Proc Natl Acad Sci USA 100 15 2003 8621 8623
5. L.M. Wakefield, and A.B. Roberts TGF-beta signaling: positive and negative effects on tumorigenesis Curr Opin Genet Dev 12 1 2002 22 29
6. D. Danielpour Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate Eur J Cancer 41 6 2005 846 857
7. J.L. Wrana TGF-beta receptors and signalling mechanisms Miner Electrolyte Metab 24 2-3 1998 120 130
8. J.L. Wrana Regulation of Smad activity Cell 100 2 2000 189 192
9. J.L. Wrana, and L. Attisano MAD-related proteins in TGF-beta signalling Trends Genet 12 12 1996 493 496
10. I.Y. Kim, H.J. Ahn, S. Lang, M.G. Oefelein, R. Oyasu, and J.M. Kozlowski Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients Clin Cancer Res 4 7 1998 1625 1630
11. I.Y. Kim, H.J. Ahn, D.J. Zelner, J.W. Shaw, S. Lang, and M. Kato Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues Clin Cancer Res 2 8 1996 1255 1261
12. M.G. Brattain, S.D. Markowitz, and J.K. Willson The type II transforming growth factor-beta receptor as a tumor-suppressor gene Curr Opin Oncol 8 1 1996 49 53
13. S.J. Kim, Y.H. Im, S.D. Markowitz, and Y.J. Bang Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis Cytokine Growth Factor Rev 11 1-2 2000 159 168
14. B. Tang, K. de Castro, H.E. Barnes, W.T. Parks, L. Stewart, and E.P. Bottinger Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells Cancer Res 59 19 1999 4834 4842
15. T.A. McCaffrey, B. Du, C. Fu, P.J. Bray, T.A. Sanborn, and E. Deutsch The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance J Mol Cell Cardiol 31 9 1999 1627 1642
16. R. Baserga The IGF-I receptor in cancer research Exp Cell Res 253 1 1999 1 6
17. R. Baserga, A. Hongo, M. Rubini, M. Prisco, and B. Valentinis The IGF-I receptor in cell growth, transformation and apoptosis Biochim Biophys Acta 1332 3 1997 F105 F126
18. R. Baserga, and A. Morrione Differentiation and malignant transformation: two roads diverged in a wood J Cell Biochem Suppl. 32-33 1999 68 75
19. H. Olivecrona, A. Hilding, C. Ekstrom, H. Barle, B. Nyberg, and C. Moller Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans J Clin Endocrinol Metab 84 2 1999 553 560
20. P.F. Collett-Solberg, and P. Cohen Genetics, chemistry, and function of the IGF/IGFBP system Endocrine 12 2 2000 121 136
21. S.J. Moschos, and C.S. Mantzoros The role of the IGF system in cancer: from basic to clinical studies and clinical applications Oncology 63 4 2002 317 332
22. M. Barinaga Study suggests new way to gauge prostate cancer risk Science 279 5350 1998 475
23. J.M. Chan, M.J. Stampfer, E. Giovannucci, P.H. Gann, J. Ma, and P. Wilkinson Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study Science 279 5350 1998 563 566
24. P. Stattin, A. Bylund, S. Rinaldi, C. Biessy, H. Dechaud, and U.H. Stenman Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study J Natl Cancer Inst 92 23 2000 1910 1917
25. E. Giovannucci Insulin-like growth factor-I and binding protein-3 and risk of cancer Horm Res 51 Suppl. 3 1999 34 41
26. P.J. bKaplan, S. Mohan, P. Cohen, B.A. Foster, and N.M. Greenberg The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model Cancer Res 59 9 1999 2203 2209
27. J. DiGiovanni, K. Kiguchi, A. Frijhoff, E. Wilker, D.K. Bol, and L. Beltran Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice Proc Natl Acad Sci USA 97 7 2000 3455 3460
28. A. Ullrich, A. Gray, A.W. Tam, T. Yang-Feng, M. Tsubokawa, and C. Collins Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity Embo J 5 10 1986 2503 2512
29. J. Dupont, and D. LeRoith Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction Horm Res 55 Suppl. 2 2001 22 26
30. A. Hongo, C. D'Ambrosio, M. Miura, A. Morrione, and R. Baserga Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor Oncogene 12 6 1996 1231 1238
31. S. Shimasaki, and N. Ling Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6) Prog Growth Factor Res 3 4 1991 243 266
32. H.S. Kim, S.R. Nagalla, Y. Oh, E. Wilson, C.T. Roberts Jr., and R.G. Rosenfeld Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily Proc Natl Acad Sci USA 94 24 1997 12981 12986
33. L. Jerome, L. Shiry, and B. Leyland-Jones Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions Endocr Relat Cancer 10 4 2003 561 578
34. R.C. Baxter, and J. Dai Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex Endocrinology 134 2 1994 848 852
35. W. Zumkeller IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth? Mol Pathol 54 5 2001 285 288
36. D.J. Withers Insulin receptor substrate proteins and neuroendocrine function Biochem Soc Trans 29 Pt 4 2001 525 529
37. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M.F. White The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J Biol Chem 275 12 2000 9047 9054
38. Z. Gao, D. Hwang, F. Bataille, M. Lefevre, D. York, and M.J. Quon Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex J Biol Chem 277 50 2002 48115 48121
39. N. Begum, O.A. Sandu, M. Ito, S.M. Lohmann, and A. Smolenski Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells J Biol Chem 277 8 2002 6214 6222
40. Y.F. Liu, K. Paz, A. Herschkovitz, A. Alt, T. Tennenbaum, and S.R. Sampson Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins J Biol Chem 276 17 2001 14459 14465
41. C.J. Carlson, M.F. White, and C.M. Rondinone Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation Biochem Biophys Res Commun 316 2 2004 533 539
42. S.S. Huang, S.M. Leal, C.L. Chen, I.H. Liu, and J.S. Huang Identification of insulin receptor substrate proteins as key molecules for the TbetaR-V/LRP-1-mediated growth inhibitory signaling cascade in epithelial and myeloid cells Faseb J 18 14 2004 1719 1721
43. K.E. Anderson, and S.P. Jackson Class I phosphoinositide 3-kinases Int J Biochem Cell Biol 35 7 2003 1028 1033
44. H. Misawa, M. Ohtsubo, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, and A. Yoshimura Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain Biochem Biophys Res Commun 244 2 1998 531 539
45. A. Tassa, M.P. Roux, D. Attaix, and D.M. Bechet Class III phosphoinositide 3-kinase-Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes Biochem J 376 Pt 3 2003 577 786
46. C. Czupalla, B. Nurnberg, and E. Krause Analysis of class I phosphoinositide 3-kinase autophosphorylation sites by mass spectrometry Rapid Commun Mass Spectrom 17 7 2003 690 696
47. G. Pandini, R. Mineo, F. Frasca, C.T. Roberts Jr., M. Marcelli, and R. Vigneri Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells Cancer Res 65 5 2005 1849 1857
48. D.M. Klotz, S.C. Hewitt, P. Ciana, M. Raviscioni, J.K. Lindzey, and J. Foley Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk J Biol Chem 277 10 2002 8531 8537
49. S.M. Aronica, and B.S. Katzenellenbogen Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I Mol Endocrinol 7 6 1993 743 752
50. Z.Q. Ma, S. Santagati, C. Patrone, G. Pollio, E. Vegeto, and A. Maggi Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3 Mol Endocrinol 8 7 1994 910 918
51. S. Kahlert, S. Nuedling, M. van Eickels, H. Vetter, R. Meyer, and C. Grohe Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway J Biol Chem 275 24 2000 18447 18453
52. J.L. Burgaud, and R. Baserga Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor Exp Cell Res 223 2 1996 412 419
53. A. Besson, S.M. Robbins, and V.W. Yong PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis Eur J Biochem 263 3 1999 605 611
54. D.M. Li, and H. Sun TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta Cancer Res 57 11 1997 2124 2129
55. P. Cairns, K. Okami, S. Halachmi, N. Halachmi, M. Esteller, and J.G. Herman Frequent inactivation of PTEN/MMAC1 in primary prostate cancer Cancer Res 57 22 1997 4997 5000
56. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, and S.I. Wang PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 5308 1997 1943 1947
57. R.J. Vlietstra, D.C. van Alewijk, K.G. Hermans, G.J. van Steenbrugge, and J. Trapman Frequent inactivation of PTEN in prostate cancer cell lines and xenografts Cancer Res 58 13 1998 2720 2723
58. V. Stambolic, A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, and T. Sasaki Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1 1998 29 39
59. X. Wu, K. Senechal, M.S. Neshat, Y.E. Whang, and C.L. Sawyers The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway Proc Natl Acad Sci USA 95 26 1998 15587 15591
60. H.K. Yi, S.Y. Kim, P.H. Hwang, C.Y. Kim, D.H. Yang, and Y. Oh Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells Biochem Biophys Res Commun 330 3 2005 760 767
61. Y. Lu, Q. Yu, J.H. Liu, J. Zhang, H. Wang, and D. Koul Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades J Biol Chem 278 41 2003 40057 40066
62. L.D. Mayo, and D.B. Donner The PTEN, Mdm2, p53 tumor suppressor- oncoprotein network Trends Biochem Sci 27 9 2002 462 467
63. D.J. Carver, M.J. Aman, and K.S. Ravichandran SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization Blood 96 4 2000 1449 1456
64. H. Valderrama-Carvajal, E. Cocolakis, A. Lacerte, E.H. Lee, G. Krystal, and S. Ali Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP Nat Cell Biol 4 12 2002 963 969
65. K.M. Nicholson, and N.G. Anderson The protein kinase B/Akt signalling pathway in human malignancy Cell Signal 14 5 2002 381 395
66. P.J. Coffer, J. Jin, and J.R. Woodgett Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation Biochem J 335 Pt 1 1998 1 13
67. D.R. Alessi, M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, and P. Cohen Mechanism of activation of protein kinase B by insulin and IGF-1 Embo J 15 23 1996 6541 6551
68. J.R. Bayascas, and D.R. Alessi Regulation of Akt/PKB Ser-473 phosphorylation Mol Cell 18 2 2005 143 145
69. H. Welch, A. Eguinoa, L.R. Stephens, and P.T. Hawkins Protein kinase B and rac are activated in parallel within a phosphatidylinositide 3OH-kinase-controlled signaling pathway J Biol Chem 273 18 1998 11248 11256
70. M. Andjelkovic, D.R. Alessi, R. Meier, A. Fernandez, N.J. Lamb, and M. Frech Role of translocation in the activation and function of protein kinase B J Biol Chem 272 50 1997 31515 31524
71. R. Meier, D.R. Alessi, P. Cron, M. Andjelkovic, and B.A. Hemmings Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta J Biol Chem 272 48 1997 30491 30497
72. S.R. James, C.P. Downes, R. Gigg, S.J. Grove, A.B. Holmes, and D.R. Alessi Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4, 5-trisphosphate without subsequent activation Biochem J 315 Pt 3 1996 709 713
73. M.E. Stearns, F.U. Garcia, K. Fudge, J. Rhim, and M. Wang Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice Clin Cancer Res 5 3 1999 711 720
74. K.E. Anderson, J. Coadwell, L.R. Stephens, and P.T. Hawkins Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B Curr Biol 8 12 1998 684 691
75. N. Pullen, P.B. Dennis, M. Andjelkovic, A. Dufner, S.C. Kozma, and B.A. Hemmings Phosphorylation and activation of p70s6k by PDK1 Science 279 5351 1998 707 710
76. A. Casamayor, N.A. Morrice, and D.R. Alessi Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo Biochem J 342 Pt 2 1999 287 292
77. L. Stephens, K. Anderson, D. Stokoe, H. Erdjument-Bromage, G.F. Painter, and A.B. Holmes Protein kinase B kinases that mediate phosphatidylinositol 3,4, 5-trisphosphate-dependent activation of protein kinase B Science 279 5351 1998 710 714
78. D.R. Alessi, S.R. James, C.P. Downes, A.B. Holmes, P.R. Gaffney, and C.B. Reese Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr Biol 7 4 1997 261 269
79. B. Vanhaesebroeck, and D.R. Alessi The PI3K-PDK1 connection: more than just a road to PKB Biochem J 346 Pt 3 2000 561 576
80. A. Mora, D. Komander, D.M. van Aalten, and D.R. Alessi PDK1, the master regulator of AGC kinase signal transduction Semin Cell Dev Biol 15 2 2004 161 170
81. Y. Taniyama, D.S. Weber, P. Rocic, L. Hilenski, M.L. Akers, and J. Park Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions Mol Cell Biol 23 22 2003 8019 8029
82. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 6835 2001 355 365
83. H.K. Lin, S. Yeh, H.Y. Kang, and C. Chang Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor Proc Natl Acad Sci USA 98 13 2001 7200 7205
84. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2 7 2002 489 501
85. G. Song, G. Ouyang, and S. Bao The activation of Akt/PKB signaling pathway and cell survival J Cell Mol Med 9 1 2005 59 71
86. D.P. Brazil, J. Park, and B.A. Hemmings PKB binding proteins. Getting in on the Akt Cell 111 3 2002 293 303
87. R.H. Chen, Y.H. Su, R.L. Chuang, and T.Y. Chang Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway Oncogene 17 15 1998 1959 1968
88. R. Rajah, B. Valentinis, and P. Cohen Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism J Biol Chem 272 18 1997 12181 12188
89. P. Cohen, R. Rajah, J. Rosenbloom, and D.J. Herrick IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol 278 3 2000 L545 L551
90. Y. Oh, H.L. Muller, L. Ng, and R.G. Rosenfeld Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action J Biol Chem 270 23 1995 13589 13592
91. S.M. Leal, Q. Liu, S.S. Huang, and J.S. Huang The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor J Biol Chem 272 33 1997 20572 20576
92. G.R. Han, D.F. Dohi, H.Y. Lee, R. Rajah, G.L. Walsh, and W.K. Hong All-trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway J Biol Chem 272 21 1997 13711 13716
93. Q. Liu, S.S. Huang, and J.S. Huang Function of the type V transforming growth factor beta receptor in transforming growth factor beta-induced growth inhibition of mink lung epithelial cells J Biol Chem 272 30 1997 18891 18895
94. S.S. Huang, T.Y. Ling, W.F. Tseng, Y.H. Huang, F.M. Tang, and S.M. Leal Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1 Faseb J 17 14 2003 2068 2081
95. W.F. Tseng, S.S. Huang, and J.S. Huang LRP-1/TbetaR-V mediates TGF-beta1-induced growth inhibition in CHO cells FEBS Lett 562 1-3 2004 71 78
96. Y. Gui, and L.J. Murphy Interaction of insulin-like growth factor binding protein-3 with latent transforming growth factor-beta binding protein-1 Mol Cell Biochem 250 1-2 2003 189 195
97. C. Schmid, C. Ghirlanda-Keller, and J. Zapf Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects Eur J Endocrinol 145 2 2001 213 221
98. K. Song, S.C. Cornelius, M. Reiss, and D. Danielpour Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2 J Biol Chem 278 40 2003 38342 38351
99. A.Y. Hsing, K. Kadomatsu, M.J. Bonham, and D. Danielpour Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines Cancer Res 56 22 1996 5146 5149
100. D. Danielpour Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta J Cell Sci 112 Pt 2 1999 169 179
101. L.V. Stewart, K. Song, A.Y. Hsing, and D. Danielpour Regulation of trespin expression by modulators of cell growth, differentiation, and apoptosis in prostatic epithelial cells Exp Cell Res 284 2 2003 303 315
102. A.R. Conery, Y. Cao, E.A. Thompson, C.M. Townsend Jr., T.C. Ko, and K. Luo Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis Nat Cell Biol 6 4 2004 366 372
103. I. Remy, A. Montmarquette, and S.W. Michnick PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3 Nat Cell Biol 6 4 2004 358 365
104. I. Navarro, B. Leibush, T.W. Moon, E.M. Plisetskaya, N. Banos, and E. Mendez Insulin, insulin-like growth factor-I (IGF-I) and glucagon: the evolution of their receptors Comp Biochem Physiol B Biochem Mol Biol 122 2 1999 137 153
105. R.G. Rosenfeld, and R.L. Hintz Characterization of a specific receptor for somatomedin C (SM-C) on cultured human lymphocytes: evidence that SM-C modulates homologous receptor concentration Endocrinology 107 6 1980 1841 1848
106. K. Megyesi, C.R. Kahn, J. Roth, D.M. Neville Jr., S.P. Nissley, and R.E. Humbel The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor J Biol Chem 250 23 1975 8990 8996
107. Y. Kang, and J. Massague Epithelial-mesenchymal transitions: twist in development and metastasis Cell 118 3 2004 277 279
108. A.V. Bakin, A.K. Tomlinson, N.A. Bhowmick, H.L. Moses, and C.L. Arteaga Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration J Biol Chem 275 47 2000 36803 36810
109. I. Shin, A.V. Bakin, U. Rodeck, A. Brunet, and C.L. Arteaga Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1 Mol Biol Cell 12 11 2001 3328 3339
110. S. Miura, T. Takeshita, H. Asao, Y. Kimura, K. Murata, and Y. Sasaki Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA Mol Cell Biol 20 24 2000 9346 9355
111. T. Tsukazaki, T.A. Chiang, A.F. Davison, L. Attisano, and J.L. Wrana SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor Cell 95 6 1998 779 791
112. S. Kunzmann, J.G. Wohlfahrt, S. Itoh, H. Asao, M. Komada, and C.A. Akdis SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression Faseb J 17 2 2003 194 202
113. D. Goto, H. Nakajima, Y. Mori, K. Kurasawa, N. Kitamura, and I. Iwamoto Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling Biochem Biophys Res Commun 281 5 2001 1100 1105
114. J.Y. Yi, I. Shin, and C.L. Arteaga Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase J Biol Chem 280 11 2005 10870 10876
115. M.P. Ebert, G. Fei, L. Schandl, C. Mawrin, K. Dietzmann, and P. Herrera Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1 Br J Cancer 86 2 2002 257 262
116. C.E. Runyan, H.W. Schnaper, and A.C. Poncelet The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1 J Biol Chem 279 4 2004 2632 2639
117. B. Janji, C. Melchior, L. Vallar, and N. Kieffer Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation Oncogene 19 27 2000 3069 3077
118. C. Melchior, S. Kreis, B. Janji, and N. Kieffer Promoter characterization and genomic organization of the gene encoding integrin-linked kinase 1 Biochim Biophys Acta 1575 1-3 2002 117 122
119. Y.I. Lee, Y.J. Kwon, and C.K. Joo Integrin-linked kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition Biochem Biophys Res Commun 316 4 2004 997 1001
120. S.N. Sehgal, H. Baker, and C. Vezina Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization J Antibiot (Tokyo) 28 10 1975 727 7232
121. C. Vezina, A. Kudelski, and S.N. Sehgal Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle J Antibiot (Tokyo) 28 10 1975 721 726
122. H. Baker, A. Sidorowicz, S.N. Sehgal, and C. Vezina Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation J Antibiot (Tokyo) 31 6 1978 539 545
123. R.R. Martel, J. Klicius, and S. Galet Inhibition of the immune response by rapamycin, a new antifungal antibiotic Can J Physiol Pharmacol 55 1 1977 48 51
124. C.P. Eng, S.N. Sehgal, and C. Vezina Activity of rapamycin (AY-22,989) against transplanted tumors J Antibiot (Tokyo) 37 10 1984 1231 1237
125. D.P. Houchens, A.A. Ovejera, S.M. Riblet, and D.E. Slagel Human brain tumor xenografts in nude mice as a chemotherapy model Eur J Cancer Clin Oncol 19 6 1983 799 805
126. J.S. Eshleman, B.L. Carlson, A.C. Mladek, B.D. Kastner, K.L. Shide, and J.N. Sarkaria Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy Cancer Res 62 24 2002 7291 7297
127. L. Wu, D.C. Birle, and I.F. Tannock Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts Cancer Res 65 7 2005 2825 2831
128. W.H. Mondesire, W. Jian, H. Zhang, J. Ensor, M.C. Hung, and G.B. Mills Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells Clin Cancer Res 10 20 2004 7031 7042
129. B. Geoerger, K. Kerr, C.B. Tang, K.M. Fung, B. Powell, and L.N. Sutton Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy Cancer Res 61 4 2001 1527 1532
130. J.E. Dancey Inhibitors of the mammalian target of rapamycin Expert Opin Investig Drugs 14 3 2005 313 328
131. J.E. Dancey Molecular targeting: PI3 kinase pathway Ann Oncol 15 Suppl. 4:iv 2004 233 239
132. S.M. Chang, J. Kuhn, P. Wen, H. Greenberg, D. Schiff, and C. Conrad Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs Invest New Drugs 22 4 2004 427 435
133. J.E. Dancey Clinical development of mammalian target of rapamycin inhibitors Hematol Oncol Clin North Am 16 5 2002 1101 1114
134. M.C. Lorenz, and J. Heitman TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin J Biol Chem 270 46 1995 27531 27537
135. C.J. Sabers, M.M. Martin, G.J. Brunn, J.M. Williams, F.J. Dumont, and G. Wiederrecht Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells J Biol Chem 270 2 1995 815 822
136. K. Hara, K. Yonezawa, Q.P. Weng, M.T. Kozlowski, C. Belham, and J. Avruch Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism J Biol Chem 273 23 1998 14484 14494
137. S.R. Kimball, L.M. Shantz, R.L. Horetsky, and L.S. Jefferson Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6 J Biol Chem 274 17 1999 11647 11652
138. K. Peyrollier, E. Hajduch, A.S. Blair, R. Hyde, and H.S. Hundal l-Leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the l-leucine-induced up-regulation of system A amino acid transport Biochem J 350 Pt 2: 2000 361 368
139. T. Schmelzle, and M.N. Hall TOR, a central controller of cell growth Cell 103 2 2000 253 262
140. J. Heitman, N.R. Movva, P.C. Hiestand, and M.N. Hall FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae Proc Natl Acad Sci USA 88 5 1991 1948 1952
141. T. Wang, and P.K. Donahoe The immunophilin FKBP12: a molecular guardian of the TGF-beta family type I receptors Front Biosci 9 2004 619 631
142. T. Okadome, E. Oeda, M. Saitoh, H. Ichijo, H.L. Moses, and K. Miyazono Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo J Biol Chem 271 36 1996 21687 21690
143. B. Aghdasi, K. Ye, A. Resnick, A. Huang, H.C. Ha, and X. Guo FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle Proc Natl Acad Sci USA 98 5 2001 2425 2430
144. M. Huse, T.W. Muir, L. Xu, Y.G. Chen, J. Kuriyan, and J. Massague The TGF beta receptor activation process: an inhibitor- to substrate-binding switch Mol Cell 8 3 2001 671 682
145. K. Hara, K. Yonezawa, M.T. Kozlowski, T. Sugimoto, K. Andrabi, and Q.P. Weng Regulation of eIF-4E BP1 phosphorylation by mTOR J Biol Chem 272 42 1997 26457 26463
146. K.J. Heesom, and R.M. Denton Dissociation of the eukaryotic initiation factor-4E/4E-BP1 complex involves phosphorylation of 4E-BP1 by an mTOR-associated kinase FEBS Lett 457 3 1999 489 493
147. G.G. Chiang, and R.T. Abraham Phosphorylation of mTOR at Ser-2448 is mediated by p70S6 kinase J Biol Chem 2005
148. A.R. Tee, B.D. Manning, P.P. Roux, L.C. Cantley, and J. Blenis Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb Curr Biol 13 15 2003 1259 1268
149. D.H. Kim, D.D. Sarbassov, S.M. Ali, R.R. Latek, K.V. Guntur, and H. Erdjument-Bromage GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR Mol Cell 11 4 2003 895 904
150. D.H. Kim, D.D. Sarbassov, S.M. Ali, J.E. King, R.R. Latek, and H. Erdjument-Bromage mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 110 2 2002 163 175
151. S.M. Ali, and D.M. Sabatini Structure of S6 kinase 1 determines whether raptor-mTOR or Rictor-mTOR phosphorylates its hydrophobic motif site J Biol Chem 280 20 2005 19445 19448
152. D. Sarbassov dos, D.A. Guertin, S.M. Ali, and D.M. Sabatini Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 307 5712 2005 1098 1101
153. D.D. Sarbassov, S.M. Ali, D.H. Kim, D.A. Guertin, R.R. Latek, and H. Erdjument-Bromage Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Curr Biol 14 14 2004 1296 1302
154. H. Nojima, C. Tokunaga, S. Eguchi, N. Oshiro, S. Hidayat, and K. Yoshino The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif J Biol Chem 278 18 2003 15461 15464
155. K. Yonezawa, K.I. Yoshino, C. Tokunaga, and K. Hara Kinase activities associated with mTOR Curr Top Microbiol Immunol 279 2004 271 282
156. M.K. Holz, and J. Blenis Identification of S6K1 as a novel mTOR-phosphorylating kinase J Biol Chem 280 2005 26089 26093
157. B.D. Manning, and L.C. Cantley United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling Biochem Soc Trans 31 Pt 3 2003 573 578
158. A.R. Tee, D.C. Fingar, B.D. Manning, D.J. Kwiatkowski, L.C. Cantley, and J. Blenis Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signalling Proc Natl Acad Sci USA 99 21 2002 13571 13576
159. A.R. Tee, R. Anjum, and J. Blenis Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin J Biol Chem 278 39 2003 37288 37296
160. K. Inoki, Y. Li, T. Zhu, J. Wu, and K.L. Guan TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Nat Cell Biol 4 9 2002 648 657
161. B.D. Manning, A.R. Tee, M.N. Logsdon, J. Blenis, and L.C. Cantley Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway Mol Cell 10 1 2002 151 162
162. K. Inoki, Y. Li, T. Xu, and K.L. Guan Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling Genes Dev 17 15 2003 1829 1834
163. A. Garami, F.J. Zwartkruis, T. Nobukuni, M. Joaquin, M. Roccio, and H. Stocker Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 Mol Cell 11 6 2003 1457 1466
164. M.C. Birchenall-Roberts, T. Fu, O.S. Bang, M. Dambach, J.H. Resau, and C.L. Sadowski Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways J Biol Chem 279 24 2004 25605 25613
165. K.U. Birkenkamp, and P.J. Coffer Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors Biochem Soc Trans 31 Pt 1 2003 292 297
166. J. Seoane, H.V. Le, L. Shen, S.A. Anderson, and J. Massague Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation Cell 117 2 2004 211 223
167. J. Gilley, P.J. Coffer, and J. Ham FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons J Cell Biol 162 4 2003 613 622
168. A. Sunters, S. Fernandez de Mattos, M. Stahl, J.J. Brosens, G. Zoumpoulidou, and C.A. Saunders FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines J Biol Chem 278 50 2003 49795 49805
169. P. Rotwein Two insulin-like growth factor I messenger RNAs are expressed in human liver Proc Natl Acad Sci USA 83 1 1986 77 81
170. L.J. Crossley Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl-1 J Leukoc Biol 74 4 2003 583 592
171. M. Gajewska, and T. Motyl IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells Comp Biochem Physiol C Toxicol Pharmacol 139 1-3 2004 65 75
172. A. Ullrich, C.H. Berman, T.J. Dull, A. Gray, and J.M. Lee Isolation of the human insulin-like growth factor I gene using a single synthetic DNA probe Embo J 3 2 1984 361 364
173. S. Kornfeld Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors Annu Rev Biochem 61 1992 307 330
174. Y.T. Tai, K. Podar, L. Catley, Y.H. Tseng, M. Akiyama, and R. Shringarpure Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3′-kinase/AKT signaling Cancer Res 63 18 2003 5850 5858
175. M. Resnicoff, J.L. Burgaud, H.L. Rotman, D. Abraham, and R. Baserga Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors Cancer Res 55 17 1995 3739 3741
176. Y. Oh, S.R. Nagalla, Y. Yamanaka, H.S. Kim, E. Wilson, and R.G. Rosenfeld Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II J Biol Chem 271 48 1996 30322 30325
177. S.S. Huang, S.M. Leal, C.L. Chen, I.H. Liu, and J.S. Huang Cellular growth inhibition by TGF-beta1 involves IRS proteins FEBS Lett 565 1-3 2004 117 121
178. S. Tanaka, and J.R. Wands Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis Cancer Res 56 15 1996 3391 3394
179. W. Link, A. Rosado, J. Fominaya, J.E. Thomas, and A. Carnero Membrane localization of all class I PI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt J Cell Biochem 2005
180. J.C. Horowitz, D.Y. Lee, M. Waghray, V.G. Keshamouni, P.E. Thomas, and H. Zhang Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor J Biol Chem 279 2 2004 1359 1367
181. S. Persad, S. Attwell, V. Gray, N. Mawji, J.T. Deng, and D. Leung Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343 J Biol Chem 276 29 2001 27462 27469
182. A. Romanelli, K.A. Martin, and A. Toker Blenis J. p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex Mol Cell Biol 19 4 1999 2921 2928
183. M.P. Scheid, M. Parsons, and J.R. Woodgett Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation Mol Cell Biol 25 6 2005 2347 2363
184. C. Leung-Hagesteijn, A. Mahendra, I. Naruszewicz, and G.E. Hannigan Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1 Embo J 20 9 2001 2160 2170
185. M. Delcommenne, C. Tan, V. Gray, L. Rue, J. Woodgett, and S. Dedhar Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase Proc Natl Acad Sci USA 95 19 1998 11211 11216
186. D.K. Lynch, C.A. Ellis, P.A. Edwards, and I.D. Hiles Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism Oncogene 18 56 1999 8024 8032
187. S. Masure, B. Haefner, J.J. Wesselink, E. Hoefnagel, E. Mortier, and P. Verhasselt Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3 Eur J Biochem 265 1 1999 353 360
188. Z.Q. Yuan, R.I. Feldman, G.E. Sussman, D. Coppola, S.V. Nicosia, and J.Q. Cheng AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance J Biol Chem 278 26 2003 23432 23440
189. K. Du, S. Herzig, R.N. Kulkarni, and M. Montminy TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver Science 300 5625 2003 1574 1577
190. H.C. Dan, M. Sun, S. Kaneko, R.I. Feldman, S.V. Nicosia, and H.G. Wang Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP) J Biol Chem 279 7 2004 5405 5412
191. J. Laine, G. Kunstle, T. Obata, M. Sha, and M. Noguchi The protooncogene TCL1 is an Akt kinase coactivator Mol Cell 6 2 2000 395 407
192. G. Kunstle, J. Laine, G. Pierron, S. Kagami Si, H. Nakajima, and F. Hoh Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1 Mol Cell Biol 22 5 2002 1513 1525
193. T. Sugatani, and K.A. Hruska Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors J Biol Chem 280 5 2005 3583 3589
194. S. Birkey Reffey, J.U. Wurthner, W.T. Parks, A.B. Roberts, and C.S. Duckett X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling J Biol Chem 276 28 2001 26542 26549
195. D.D. Sarbassov, D.A. Guertin, S.M. Ali, and D.M. Sabatini Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 307 5712 2005 1098 1101
196. S. Han, T.M. Santos, A. Puga, J. Roy, E.A. Thiele, and M. McCollin Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions Cancer Res 64 3 2004 812 816
197. O.J. Shah, Z. Wang, and T. Hunter Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies Curr Biol 14 18 2004 1650 1656
198. A. Brunet, A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, and L.S. Hu Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 6 1999 857 868
199. H. Tran, A. Brunet, J.M. Grenier, S.R. Datta, A.J. Fornace Jr., and P.S. DiStefano DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein Science 296 5567 2002 530 534
200. H. Tran, A. Brunet, E.C. Griffith, and M.E. Greenberg The many forks in FOXO's road Sci STKE 2003 172 2003 RE5
201. T.R. Kau, F. Schroeder, S. Ramaswamy, C.L. Wojciechowski, J.J. Zhao, and T.M. Roberts A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells Cancer Cell 4 6 2003 463 476
202. M. Stahl, P.F. Dijkers, G.J. Kops, S.M. Lens, P.J. Coffer, and B.M. Burgering The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2 J Immunol 168 10 2002 5024 5031
203. C. Urbich, A. Knau, S. Fichtlscherer, D.H. Walter, T. Bruhl, and M. Potente FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells Faseb J 19 2005 974 976
204. A. Essafi, S. Fernandez de Mattos, Y.A. Hassen, I. Soeiro, G.J. Mufti, and N.S. Thomas Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells Oncogene 24 14 2005 2317 2329
205. M.C. Hu, D.F. Lee, W. Xia, L.S. Golfman, F. Ou-Yang, and J.Y. Yang IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a Cell 117 2 2004 225 237
206. G.P. Kaushal, L. Liu, V. Kaushal, X. Hong, O. Melnyk, and R. Seth Regulation of caspase-3 and -9 activation in oxidant stress to RTE by forkhead transcription factors, Bcl-2 proteins, and MAP kinases Am J Physiol Renal Physiol 287 6 2004 F1258 F1268
207. C. Dai, J. Yang, and Y. Liu Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling J Biol Chem 278 14 2003 12537 12545
208. L. Soane, H.J. Cho, F. Niculescu, H. Rus, and M.L. Shin C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway J Immunol 167 4 2001 2305 2311
209. S. Zhao, M. Konopleva, M. Cabreira-Hansen, Z. Xie, W. Hu, and M. Milella Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias Leukemia 18 2 2004 267 275
210. T. Wang, P.K. Donahoe, and A.S. Zervos Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12 Science 265 5172 1994 674 676
211. M. Huse, Y.G. Chen, J. Massague, and J. Kuriyan Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12 Cell 96 3 1999 425 436
212. Y.G. Chen, F. Liu, and J. Massague Mechanism of TGFbeta receptor inhibition by FKBP12 Embo J 16 13 1997 3866 3876